Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

8.45
+0.08000.96%
Post-market: 8.590.1383+1.64%19:59 EDT
Volume:986.65K
Turnover:8.38M
Market Cap:437.46M
PE:-39.69
High:8.60
Open:8.39
Low:8.35
Close:8.37
52wk High:14.06
52wk Low:5.62
Shares:51.77M
Float Shares:51.26M
Volume Ratio:1.54
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2129
EPS(LYR):0.9300
ROE:-1.60%
ROA:3.43%
PB:0.84
PE(LYR):9.09

Loading ...

Emergent BioSolutions to present at Jefferies Global Healthcare Conference

Reuters
·
May 20

Saudi regulator SFDA approves Emergent ACAM2000 vaccine for smallpox, mpox prevention

Reuters
·
May 18

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for Acam2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

THOMSON REUTERS
·
May 18

Press Release: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

TIPRANKS
·
May 02

Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

TIPRANKS
·
May 01

Emergent BioSolutions Q1 Revenue USD 156.1 Million

Reuters
·
May 01

Emergent BioSolutions Q1 Adj. EPS $0.21 Beats $(0.25) Estimate, Sales $156.100M Beat $145.000M Estimate

Benzinga
·
May 01

Emergent BioSolutions Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 01

Emergent BioSolutions Outlook FY Adjusted Net Income USD 45-65 Million

THOMSON REUTERS
·
May 01

Emergent BioSolutions Q1 Gross Margin 41%

THOMSON REUTERS
·
May 01

Emergent BioSolutions receives Singapore regulatory approval for ACAM2000

TIPRANKS
·
Apr 30

BRIEF-Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority

Reuters
·
Apr 30

Singapore HSA approves Emergent ACAM2000 vaccine label expansion to include mpox

Reuters
·
Apr 30

Emergent BioSolutions shareholders approved amendment to increase stock incentive plan shares

Reuters
·
Apr 30

Emergent BioSolutions Inc: Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions Inc - Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions: Under Terms, Co to Provide End-to-End Development, Manufacturing Services to SAB Bio

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

GlobeNewswire
·
Apr 29